Insights On Clinical Technologies

  1. EDC Clinical Trials: What Needs To Be Considered When Implementing A Protocol Amendment To Your EDC?
    10/10/2018

    Why being prepared, thinking big, and getting organized are important when implementing a protocol amendment to your EDC.

  2. Trial Results Summaries: Improving Patient Communications
    10/4/2018

    This paper discusses the challenges inherent in the current practices of providing trial results summaries to trial participants. It presents an alternative approach to distributing trial results summaries that takes advantage of commonly used technologies to more quickly, efficiently and reliably provide trial results summaries to trial participants. The benefits of this approach to clinical trial sponsors, patients, and their relationship with each other are also discussed.

  3. Mobile eTMF: Once A “Would-Be-Nice”. Now A “Must-Have”!
    10/2/2018

    The benefits of off­ering a mobile experience are simply too great to ignore.

  4. Maximizing Efficiencies In Site Enrollment II - Confidentiality Disclosure Agreements
    9/27/2018

    Five common CDA pain points that can make a simple sounding agreement so challenging for clinical teams.

  5. MHRA’s GCP Findings: It’s About Oversight
    9/25/2018

    Hone in on the critical findings around the TMF and recording/keeping of essential documents.

  6. A Top 10 Sponsor Improves Trial Data Quality Through EDC eSource Solution
    9/4/2018

    Be viewed as an industry leader while at the same time benefiting from higher quality data and a need for fewer resources with use of an innovative eSource solution.

  7. Getting to True Agile IRT: 5 Questions To Ask Your IRT Vendor
    9/4/2018

    While many vendors are claiming agile IRT capabilities, it is important to dig deeply and examine these claims – as well as a company’s proven ability to provide predictable, consistent delivery of project timelines and quality.

  8. Making eSource Work: Beyond The Hype
    9/4/2018

    Implementing eSource can mean operating differently from the norm, with potentially an initial layer of complexity before things become simpler.

  9. A Survival Guide To Temperature Data In Life Sciences
    8/22/2018

    Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire clinical supply chain.

  10. Changes to WHODrug Are Coming – Will You Be Ready?
    8/18/2018

    Why you should prepare now even with nearly a year remaining.